Immune cell therapy shows promise for tough leukemia cases
Disease control
Terminated
This study tested a treatment called TCB008, made from donated immune cells, for adults with acute myeloid leukemia (AML) that came back or didn't respond to standard therapy. The goal was to see if it could reduce cancer cells in the bone marrow. The trial was stopped early, but…
Phase: PHASE2 • Sponsor: TC Biopharm • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC